IRVINE, Calif.--(BUSINESS WIRE)--
Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Investors who purchased or otherwise acquired Abeona Therapeutics Inc. shares between March 31, 2015 and June 19, 2015; and/or Abeona shares between June 22, 2015 and December 9, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the February 14, 2017 lead plaintiff motion deadline.
If you purchased shares of Abeona during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at [email protected].
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
Mako Research published a report on SeekingAlpha.com stating, "ABEO science is demonstrably unviable with numerous irrefutable flaws that will lead to failure." The report found that Steven H. Rouhandeh, the Company's Executive Chairman and Principal Executive Officer, was once the managing director at D. Blech & Co., a brokerage firm that was the subject of SEC investigations during the 1990s, as well as a securities class action suit that ended in a $15 million investor settlement because of claims that the firm changed the price of some biotech stocks through transactions that falsely inflated the market price of the stocks.
When this information was released to the investing public, the value of Abeona fell sharply, causing investors harm.
If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at [email protected].
This press release may constitute Attorney Advertising in some jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170124006661/en/
